Navigation Links
Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its,Ghrelin Antagonist Program at the American Diabetes Association's,Annual Meeting

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 25, 2007 - Elixir Pharmaceuticals, Inc., today announced the presentation of two sets of preclinical data demonstrating that ghrelin antagonism may be a potential method for future treatment of a range of metabolic disorders. These data demonstrated a variety of beneficial metabolic effects, notably decreasing body weight, improvements in blood glucose and insulin levels, and reductions in fatty liver. The data were presented in poster sessions on Sunday, June 24th, during the American Diabetes Association's 67th Annual Scientific Sessions meeting, being held in Chicago, IL. Elixir is focused on the development of drugs to treat and prevent metabolic disease, as well as prevent age-related diseases, based on targets identified in the pathways regulating aging.

Ghrelin, which has been identified as a key metabolic regulator, is known to stimulate appetite and food consumption and is believed to play a key role in metabolism and energy storage. A naturally occurring hormone produced in the stomach, ghrelin is believed to act primarily at the level of the hypothalamus in the brain, which governs metabolism.

Elixir scientists have previously demonstrated that, compared to normal (control) mice, ghrelin receptor (GhrR) knockout mice resist the development of diabetes and obesity associated with a high-fat diet. After fifteen weeks of eating a high fat diet the normal (control) mice gained 10% more weight than GhrR knockout mice. Importantly, the knockout mice also had significantly lower blood glucose, insulin and HbA1c levels. These results illustrate the knockout mice resist the development of type 2 diabetes.

In the first poster Elixir presents data in which scientists compared the results of the GhrR knockout mice to those obtained with mice treated twice a day for up to 56 days with one of Elixir's potent, small molecule, oral GhrR antagonists. As with the Gh
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Elixir Pharmaceuticals Announces Clinical Data at American Diabetes Association Conference Highlighting Ability of Glufast to Maintain Glycemic Control in Patients with Type 2 Diabetes
2. Elixir Pharmaceuticals Presents Additional Preclinical Data Demonstrating the Potential of Ghrelin Antagonism to Regulate Metabolism, Body Weight and Glycemic Control
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
Post Your Comments:
(Date:8/27/2014)... Varian Medical Systems (NYSE: VAR) today broke ground on ... Lake City manufacturing facility and allow for the ... to ultimately create 1,000 new full time jobs ... " Utah is home to hardworking ... can be credited with Varian,s success in the manufacturing of ...
(Date:8/27/2014)... DALLAS , August 27, 2014 ... "Dental Equipment Market By Products (Dental Radiology, CAD/CAM, Dental Chairs, ... 2019" published by MarketsandMarkets, the global Dental Equipment Market ... from $5,416.3 million in 2014, growing at a ... Browse 95 market data tables and 61 ...
(Date:8/27/2014)... York , August 27, 2014 ... United States  Laparoscopes Market Outlook to 2020. ... provides key market data on the United States ... of US dollars, volume (in units) and average prices ... Tip Video Laparoscopes and Flexible Tip Video Laparoscopes), Robotic ...
Breaking Medicine Technology:Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 2Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 3Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 4Dental Equipment Market Worth $7,138.9 Million by 2019 2Dental Equipment Market Worth $7,138.9 Million by 2019 3United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 2United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 3United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 4United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 5
... , CORALVILLE, Iowa, Dec. 16 Vivakor, ... Development agreement with Baker Consulting out of Walnut Creek, ... of South Florida. Baker Consulting has been retained ... assisting the company with its recently reported acquisition strategy. ...
... Dec. 16 Naurex Inc., a new clinical stage company ... on its novel GFPA NMDA receptor modulators, today announced that ... lead compound GLYX-13 and has successfully dosed the first subjects ... agonist (GFPA) selective modulator of the NMDA receptor, is initially ...
Cached Medicine Technology:Vivakor Signs Business Development Agreement With Baker Consulting 2Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 2Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression 3
(Date:8/27/2014)... 28, 2014 BRIC Laparoscopes Market Outlook ... provides key market data on the BRIC Laparoscopes market. ... volume (in units) and average prices (in US dollars) ... and Flexible Tip Video Laparoscopes), Robotic Surgical Systems and ... of advantages to the patient with laparoscopic surgery versus ...
(Date:8/27/2014)... play a key role in inflaming blood vessels and ... study at UCLA demonstrates that they may also contribute ... the small blood vessels in the lungs. , Using ... mimicking part of the main protein in high-density lipoprotein ... production of oxidized lipids in pulmonary hypertension. They also ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Dr. ... Vision Center see multitudes of patients suffering from impaired ... and Cataract vision correction surgery . Recently, Dr. ... glaucoma information during an eye exam and also online. ... the top five myths about glaucoma. , 1)    Myth: People ...
(Date:8/27/2014)... 27, 2014 The federal judge overseeing ... has extended the deadline for plaintiffs to enroll in ... Order issued by U.S. District Judge David Katz of ... in the DePuy ASR Settlement Program must do so ... ASR Hip Implant Products Liability Litigation – MDL 2197) ...
(Date:8/27/2014)... The extensive polling of 970 ... research group Black Book Rankings uncovers several alarming ... supplied or built to care for even a ... annual survey to gain stakeholder insight into the ... and emergency preparedness systems,” said Doug Brown, Managing ...
Breaking Medicine News(10 mins):Health News:Laparoscopes & Endoscopic Reprocessors Market in BRIC (Brazil, Russia, India & China) to 2020 Report Available at RnRMarketResearch.com 2Health News:Laparoscopes & Endoscopic Reprocessors Market in BRIC (Brazil, Russia, India & China) to 2020 Report Available at RnRMarketResearch.com 3Health News:Laparoscopes & Endoscopic Reprocessors Market in BRIC (Brazil, Russia, India & China) to 2020 Report Available at RnRMarketResearch.com 4Health News:Protein in 'good cholesterol' may be a key to treating pulmonary hypertension 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Debunks Top Five Myths About Glaucoma 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Debunks Top Five Myths About Glaucoma 3Health News:Renowned Eye Surgeon Dr. Stewart Shofner Debunks Top Five Myths About Glaucoma 4Health News:DePuy ASR Settlement Enrollment Deadline Extended Until September 30, 2014, Bernstein Liebhard LLP Reports 2Health News:DePuy ASR Settlement Enrollment Deadline Extended Until September 30, 2014, Bernstein Liebhard LLP Reports 3Health News:American Hospitals Are Vastly Unprepared for Ebola Patients, Reveals Black Book™ Survey of Emergency Physicians, Nurses and Infection Control Practitioners 2Health News:American Hospitals Are Vastly Unprepared for Ebola Patients, Reveals Black Book™ Survey of Emergency Physicians, Nurses and Infection Control Practitioners 3Health News:American Hospitals Are Vastly Unprepared for Ebola Patients, Reveals Black Book™ Survey of Emergency Physicians, Nurses and Infection Control Practitioners 4
... the Doubletree Hotel in Oak Brook ... 23 The Perinatal Nursing Advisory Council and the March of ... lactation consultants, and the community to the March of Dimes ... Oak Brook, Illinois. All healthcare professionals caring for moms ...
... retinoid tretinoin not the culprit , , FRIDAY, Jan. 23 (HealthDay ... that was tried as a possible skin cancer preventative in ... of several veterans participating in that research. , The ... risk of death was seen in those using retinoid tretinoin ...
... contradicts belief that death rate associated with condition has ... death rate for patients with acute respiratory distress syndrome ... that contradicts the common belief there,s been a steady ... , The researchers reviewed studies conducted between 1984 and ...
... inflammatory bowel disease have higher concentrations of folate in their blood than ... the University of California, San Francisco and UC Berkeley. The findings bring ... to folate - also known as folic acid - deficiency. , ... ...
... Ohio, Jan. 23 Patricia A. Furlong, Founding ... (PPMD), the largest non-profit organization in the United ... muscular dystrophy (Duchenne), announced the one year anniversary ... resources and needs of the Duchenne and Becker ...
... 23 Heartland Information Services,( www.heartlandis.com ), headquartered ... outsourced transcription companies in a report released in ... firm,( www.KLASresearch.com ). In their report, Top 20 ... 2008, Heartland moved up for the third year ...
Cached Medicine News:Health News:March of Dimes 34th Annual Perinatal Conference For Nurses, Health Educators, Social Workers and Other Healthcare Pros Caring for Moms and Babies 2Health News:Acne Cream Not Linked to Raised Death Risk 2Health News:Acne Cream Not Linked to Raised Death Risk 3Health News:Acute Respiratory Distress Syndrome as Deadly as Ever 2Health News:Children with Inflammatory Bowel Disease Have Surprisingly High Folate Levels, Study Finds 2Health News:Children with Inflammatory Bowel Disease Have Surprisingly High Folate Levels, Study Finds 3Health News:Children with Inflammatory Bowel Disease Have Surprisingly High Folate Levels, Study Finds 4Health News:DuchenneConnect Celebrates One Year Anniversary 2Health News:DuchenneConnect Celebrates One Year Anniversary 3Health News:DuchenneConnect Celebrates One Year Anniversary 4Health News:Heartland Information Services Moves Up to 2nd Place in National Survey for Outsourced Transcription 2
The Onar®Lp test system is an in vitro test for the qualitative diagnosis of legionella in clinical samples....
The Onar®Lp -QP test system is an in vitro test for the quantitative diagnosis of legionella in clinical samples....
Designed for OSA patients who have difficulty with conventional CPAP therapy, the ResMed SULLIVAN Comfort system is a solution for those who need an alternative to CPAP....
... an approach to treatment that ... pressure range to 25 cm ... treat patients with severe OSA. ... integrated humidification and built-in Encore® ...
Medicine Products: